Showing results (211-220 of 1,584) with videos related to
Sort By:
Pageof 159
Antiviral Chemistry & Chemotherapy|October 3, 2003
Synthesis and antiviral activity of some 5'-N-phthaloyl-3'-azido-2',3'-dideoxythymidine analoguesJan Balzarini, Erik De Clercq, Beata Kaminska, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 7, 1999
9-(2-Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phaseS Hatse, D Schols, E De Clercq, et al.Biochemical and Biophysical Research Communications|October 26, 1999
Characterization of multiple nuclear localization signals in herpes simplex virus type 1 thymidine kinaseB Degrève, R Esnouf, E De Clercq, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPAC Ballatore, C McGuigan, E De Clercq, et al.Journal of Medicinal Chemistry|December 3, 2002
A thymidine phosphorylase-stable analogue of BVDU with significant antiviral activitySven Guenther, Jan Balzarini, Erik De Clercq, et al.Antimicrobial Agents and Chemotherapy|August 26, 2003
Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivativesMiguel Stevens, Christophe Pannecouque, Erik De Clercq, et al.Biochemistry|May 16, 2002
The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinaseJan Balzarini, Sandra Liekens, Robert Esnouf, et al.The Biochemical Journal|January 1, 1984
Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNAJ Balzarini, E De Clercq, D Ayusawa, et al.FEBS Letters|July 23, 1984
Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitorsJ Balzarini, E de Clercq, D Ayusawa, et al.Journal of Medical Virology|May 1, 1992
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency miceJ Neyts, J Balzarini, L Naesens, et al.Pageof 159